The present disclosure relates generally to inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), compositions thereof, and methods of using said compounds and compositions thereof. More specifically, the present disclosure relates to sulfoximine- based inhibitors of ENPP1 of Formula (I) and methods of their use for treating disease mediated by ENPP1.
本公开涉及一般来说是对细胞外核苷酸
焦磷酸酶/
磷酸二酯酶1(ENPP1)的
抑制剂,其组合物以及使用所述化合物和组合物的方法。更具体地说,本公开涉及基于砜
亚胺的ENPP1
抑制剂,其
化学式为(I),以及其用于治疗由ENPP1介导的疾病的方法。